Activation of CD8+tumor infiltrating lymphocytes by bavituximab in a 3D ex vivo system of lung cancer patients.

被引：1
|
作者：
Altiok, Soner
Valera, Melanie Mediavilla
Kreahling, Jenny
Noyes, David
Razabdouski, Tiffany N.
Kallinteris, Nikoletta L.
Shan, Joseph
Antonia, Scott Joseph
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Nilogen Oncosyst, Tampa, FL USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Peregrine Pharmaceut Inc, Tustin, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3060
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
    Lukman, Kiki
    Septianto, Rhandy
    Rudiman, Reno
    Ruchimat, Tommy
    Sribudiani, Yunia
    Nugraha, Prapanca
    Primastari, Etis
    Budiman, Deny
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 197 - 209
  • [42] Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response
    Rapoport, Bernardo Leon
    Nayler, Simon
    Mlecnik, Bernhard
    Smit, Teresa
    Heyman, Liezl
    Bouquet, Isabelle
    Martel, Marine
    Galon, Jerome
    Benn, Carol-Ann
    Anderson, Ronald
    CANCERS, 2022, 14 (10)
  • [43] CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
    Djenidi, Faycal
    Adam, Julien
    Goubar, Aicha
    Durgeau, Aurelie
    Meurice, Guillaume
    de Montpreville, Vincent
    Validire, Pierre
    Besse, Benjamin
    Mami-Chouaib, Fathia
    JOURNAL OF IMMUNOLOGY, 2015, 194 (07): : 3475 - 3486
  • [44] Tumor-infiltrating CD8+and FOXP3+lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
    Liang, Yun
    Lu, Weiguo
    Zhang, Xiaofei
    Lu, Bingjian
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [45] Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
    Yun Liang
    Weiguo Lü
    Xiaofei Zhang
    Bingjian Lü
    Diagnostic Pathology, 13
  • [46] Impaired ex-vivo expandability of CD56+ cytotoxic lymphocytes in autologous PBSC transplants from breast cancer patients.
    Clausen, J
    Vergeiner, B
    Petzer, AL
    Gastl, G
    Gunsilius, E
    BONE MARROW TRANSPLANTATION, 1999, 23 : S25 - S25
  • [47] An Immunoscore System Based On CD3+ And CD8+ Infiltrating Lymphocytes Densities To Predict The Outcome Of Patients With Colorectal Adenocarcinoma
    Trabelsi, Mouna
    Farah, Faten
    Zouari, Bechir
    Jaafoura, Mohamed Habib
    Kharrat, Maher
    ONCOTARGETS AND THERAPY, 2019, 12 : 8663 - 8673
  • [48] Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients
    Giatromanolaki, Alexandra
    Anestopoulos, Ioannis
    Panayiotidis, Mihalis I.
    Mitrakas, Achilleas
    Pappa, Aglaia
    Koukourakis, Michael I.
    ANTICANCER RESEARCH, 2021, 41 (08) : 3989 - 3995
  • [49] Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo S.
    Vader, Willemijn
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Absence of synergistic effects for PARPi and immunotherapy combinations in ex vivo 3D micro tumor assay for ovarian cancer patients
    Ceton, Lieke J.
    Koedoot, Esmee
    Sijsenaar, Timothy J.
    van der Meer, Dieudonne J.
    Garcia, Marta Montero
    van der Valk, Jurrian
    Maad, Kristofer
    de Kroon, Cor
    van Altena, Anne
    Vader, Willemijn
    Kroep, Judith
    Ottevanger, Nelleke
    CANCER RESEARCH, 2024, 84 (06)
12345